ChemCentre has become one of the few laboratories in Australia to be granted a Therapeutic Goods Administration licence and Good Manufacturing Practice (GMP) certification.
The licence and certification mean ChemCentre will now be able to offer analysis of final dose form medicinal cannabis products for legislative compliance based on Therapeutic Goods Order No. 93 (Standard for Medicinal Cannabis) This testing includes determination of an extensive cannabinoid profile as well as the analysis of terpenes, mycotoxins, heavy metals, pesticides, foreign matter and residual solvents, with a significant number of these analyses also being NATA accredited.
This capability can be accessed by manufacturers and distributors seeking to enter new and emerging international markets where this level of certification is required.
The accreditation also facilitates involvement in other analyses for the food, pharmaceutical and supplements industries and demonstrates to our clients our continued commitment to delivering a high-quality service.
Our highly trained scientific staff are also readily available to provide consultancy services that can assist with queries regarding product development, formulation and analysis.
Our scientists are experts at solving those difficult chemical problems, if you have questions regarding product analysis or development we are here to help.
Contact us now